Find and Pitch Jounalists, Get Your Story Covered

Tags: clozapine schizophrenia touch neutropenia mental illness

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	ADHD Drug Recall; Alcohol and Sports Gambling; Deprescribing Benzodiazepines - about 1 month ago Most Clozapine Prescribers Satisfied With REMS Program - 2 months ago 6% of Seniors Depressed; ADHD and Hormones; Novel Antipsychotic Eases Schizophrenia - 3 months ago Sotagliflozin Rejected for T1D; Thyroid and COVID; Diabetes Drug Price Cut - 4 months ago Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression - 5 months ago Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - 5 months ago Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug - 5 months ago Assessing Tardive Dyskinesia Risk - 8 months ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 8 months ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 9 months ago Fanapt OK'd for Bipolar; First Depression App Cleared; Keto Diet for Schizophrenia - about 1 year ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - over 1 year ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - over 1 year ago U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo - over 1 year ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - over 1 year ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - over 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - over 1 year ago Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud? - over 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Teva targets schizophrenia to build on innovative medicines growth - about 2 months ago Spravato is just the beginning in a new wave of depression meds - 5 months ago
3	Theresa Gaffney STAT News Audio producer, health reporter. Boston audio productionhealth reporting	People with alcohol-use disorder drank less on Ozempic, small study shows - 2 months ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Cambridge Cognition highlights positive Cantab results - 3 months ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Possible Early Symptom of Creutzfeldt-Jakob Disease Identified - 3 months ago Ozempic for Alzheimer's? What Drives Brain Age; Primary Care Alzheimer's Guideline - 4 months ago Continuous Parkinson's Disease Therapy Wins FDA Nod - 6 months ago Diabetes Drug Shows Benefit in Parkinson's Disease - about 1 year ago FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs - over 1 year ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome - 5 months ago FDA Approves Cerliponase Alfa for Expanded Indication of CLN2 Disease - 9 months ago More Research Needed for Treatment of Clozapine-Resistant Schizophrenia - about 1 year ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - about 1 year ago Brexpiprazole Demonstrates Clinically Meaningful Improvements for Agitation Due to Alzheimer Disease - over 1 year ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test - 5 months ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials - 5 months ago STAT+: Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study - 6 months ago More evidence on GLP-1s and opioid addiction - 6 months ago Parkinson’s disease may be helped by GLP-1 drug, new study finds - about 1 year ago GLP-1 drugs not linked to suicidal thoughts in FDA’s early review - over 1 year ago
9	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Clofutriben Receives FDA Orphan Drug Designation to Treat Endogenous Cushing Syndrome - 6 months ago Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy - 6 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark - 6 months ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 7 months ago STAT+: Pharmalittle: We’re reading about a study of Ozempic and dementia, smaller PBMs, and more - 9 months ago STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a failed schizophrenia drug trial, a Pfizer cancer drug, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ safety, Novartis nixing a deal, and more - over 1 year ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - over 1 year ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - over 1 year ago STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation - over 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - over 1 year ago STAT+: Pharmalittle: Eisai reports injectable version of Alzheimer’s drug as effective as IV; Pfizer says combo flu and Covid shot shows strong response - over 1 year ago

Journalists covering clozapine